Global Piriformis Syndrome Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Cause;

Trauma, Spasms, Overuse Injury, and Others.

By Diagnostic Test;

Magnetic Resonance Imaging (MRI), Computed Tomography (CT), X-Rays, Neurophysiologic Testing, Electromyography (EMG), Beatty Test, FAIR (Flexion, Adduction, And Internal Rotation) Test, and Others.

By Treatment;

Medications - NSAIDs[Naproxen, Ibuprofen and Others], Piriformis Muscle Injection[Botox Injection, Steroid Injection, and Others].

By Distribution Channel;

E-Commerce, Retail Pharmacies, and Others.

By End User;

Hospitals And Clinics, Diagnostic Centers, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn702315265 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Piriformis Syndrome Market (USD Million), 2021 - 2031

In the year 2024, the Global Piriformis Syndrome Market was valued at USD 286.35 million. The size of this market is expected to increase to USD 435.71 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.2%.

In the intricate landscape of musculoskeletal disorders, Piriformis Syndrome emerges as a condition often overlooked yet profoundly impactful. Characterized by pain, numbness, and tingling sensations in the buttocks and down the leg, this syndrome can significantly impede one's quality of life. Despite its prevalence, the understanding of Piriformis Syndrome remains in the shadows, overshadowed by more prominent musculoskeletal ailments.

The global perspective is shifting. With advancements in medical research, technology, and a growing awareness among healthcare professionals and patients alike, the spotlight is gradually turning towards Piriformis Syndrome. This shift catalyzes a pivotal moment, prompting a deeper exploration into the dynamics of this syndrome and its broader implications on the healthcare landscape.

This introduction sets the stage for an in-depth examination of the Global Piriformis Syndrome Market. Through comprehensive analysis, we aim to unravel the underlying trends, key insights, and future prospects shaping this niche yet crucial segment of the healthcare industry. From epidemiology and etiology to diagnosis, treatment modalities, and emerging therapies, our exploration endeavors to provide stakeholders with actionable intelligence to navigate and capitalize on the evolving landscape of Piriformis Syndrome.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Cause
    2. Market Snapshot, By Diagnostic Test
    3. Market Snapshot, By Treatment
    4. Market Snapshot, By Distribution Channel
    5. Market Snapshot, By End User
    6. Market Snapshot, By Region
  4. Global Piriformis Syndrome Market Trends
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Awareness
        2. Technological Advancements
        3. Aging Population
        4. Sedentary Lifestyles
      2. Restraints
        1. Limited Understanding of Syndrome
        2. Diagnostic Challenges
        3. Lack of Standardized Treatment Protocols
        4. Reimbursement Issues
      3. Opportunities
        1. Emerging Markets Expansion
        2. Development of Targeted Therapies
        3. Integration of Digital Health Solutions
        4. Collaborative Research Initiatives
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry

  5. Market Segmentation
    1. Global Piriformis Syndrome Market, By Cause, 2021 - 2031 (USD Million)
      1. Trauma
      2. Spasms
      3. Overuse Injury
      4. Others
    2. Global Piriformis Syndrome Market, By Diagnostic Test, 2021 - 2031 (USD Million)
      1. Magnetic Resonance Imaging (MRI)
      2. Computed Tomography (CT)
      3. X-Rays
      4. Neurophysiologic Testing
      5. Electromyography (EMG)
      6. Beatty Test
      7. FAIR (Flexion, Adduction, And Internal Rotation) Test
      8. Others
    3. Global Piriformis Syndrome Market, By Treatment, 2021 - 2031 (USD Million)
      1. Medications
        1. NSAIDs
          1. Naproxen
          2. Ibuprofen
          3. Others
        2. Piriformis Muscle Injection
          1. Botox Injection
          2. Steroid Injection
          3. Others
    4. Global Piriformis Syndrome Market, By Distribution Channel, 2021 - 2031 (USD Million)
      1. E-Commerce
      2. Retail Pharmacies
      3. Others
    5. Global Piriformis Syndrome Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals And Clinics
      2. Diagnostic Centers
      3. Others
    6. Global Piriformis Syndrome Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia/New Zealand
        5. South Korea
        6. ASEAN
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Bayer AG
      2. Novartis AG
      3. AstraZeneca
      4. Endo Pharmaceuticals
      5. Teva Pharmaceuticals
      6. Omron Healthcare
      7. Sanofi S.A.
      8. DePuy Synthes Companies
      9. Miracle Stretch, LLC
      10. Flex Pharma, Inc.
  7. Analyst Views
  8. Future Outlook of the Market